Ihuman INC. (IH) — SEC Filings
Latest SEC filings for Ihuman INC.. Recent 6-K filing on Mar 31, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
Overview
Ihuman INC. (IH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Mar 31, 2026: iHuman Inc. filed a Form 6-K on March 31, 2026, reporting information as a foreign issuer. The filing includes standard exhibits and documents related to their operations. The company's mailing and business addresses are both located in Beijing, China.
Sentiment Summary
Across 11 filings, the sentiment breakdown is: 11 neutral. The dominant filing sentiment for Ihuman INC. is neutral.
Filing Type Overview
Ihuman INC. (IH) has filed 9 6-K, 2 20-F with the SEC between Feb 2024 to Mar 2026.
Filings by Year
Recent Filings (11)
-
iHuman Inc. Files 6-K Report
— 6-K · Mar 31, 2026 Risk: low
iHuman Inc. filed a Form 6-K on March 31, 2026, reporting information as a foreign issuer. The filing includes standard exhibits and documents related to their -
iHuman Inc. Files December 2025 6-K Report
— 6-K · Dec 29, 2025 Risk: low
iHuman Inc. filed a Form 6-K on December 29, 2025, reporting for the month of December 2025. The filing includes a press release as Exhibit 99.1. Vivien Weiwei -
iHuman Inc. Files 6-K Report
— 6-K · Sep 18, 2025 Risk: low
iHuman Inc. filed a Form 6-K on September 18, 2025, reporting for the month of September 2025. The filing includes a press release as Exhibit 99.1. Vivien Weiwe -
iHuman Inc. Files June 2025 6-K Report
— 6-K · Jun 26, 2025 Risk: low
On June 26, 2025, iHuman Inc. filed a Form 6-K, reporting information for the month of June 2025. The filing includes a press release as Exhibit 99.1. Vivien We -
iHuman Inc. 2024 20-F: Share Repurchases Continue
— 20-F · Apr 28, 2025 Risk: medium
iHuman Inc. filed its 20-F annual report for the fiscal year ending December 31, 2024. The company, based in Beijing, China, is involved in educational services -
iHuman Inc. Files March 2025 6-K Report
— 6-K · Mar 25, 2025 Risk: low
iHuman Inc. filed a Form 6-K on March 25, 2025, reporting for the month of March 2025. The filing includes a press release as Exhibit 99.1. Vivien Weiwei Wang, -
iHuman Inc. Files 6-K Report
— 6-K · Dec 26, 2024 Risk: low
iHuman Inc. filed a Form 6-K on December 26, 2024, reporting information for the month of December 2024. The filing includes a press release as Exhibit 99.1. Vi -
iHuman Inc. Files 6-K Report
— 6-K · Sep 27, 2024 Risk: low
iHuman Inc. filed a Form 6-K on September 27, 2024, reporting information for the month of September 2024. The filing includes a press release as Exhibit 99.1. -
iHuman Inc. Files June 2024 Report (6-K)
— 6-K · Jun 28, 2024 Risk: low
iHuman Inc. filed a Form 6-K on June 28, 2024, reporting information for the month of June 2024. The filing includes a press release as Exhibit 99.1. Vivien Wei -
iHuman Inc. Files 20-F Annual Report for Fiscal Year 2023
— 20-F · Apr 25, 2024 Risk: medium
iHuman Inc. (IH) filed a Foreign Annual Report (20-F) with the SEC on April 25, 2024. iHuman Inc. filed its 20-F annual report for the fiscal year ended Decembe -
iHuman Inc. Files February 2024 Report (6-K)
— 6-K · Feb 29, 2024 Risk: low
On February 29, 2024, iHuman Inc. filed a Form 6-K, reporting information for the month of February 2024. The filing includes a press release as Exhibit 99.1. V
Risk Profile
Risk Assessment: Of IH's 11 recent filings, 0 were flagged as high-risk, 2 as medium-risk, and 9 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Vivien Weiwei Wang
Top Tags
6-K (8) · disclosure (3) · foreign-private-issuer (3) · filing (2) · press-release (2) · sec-filing (2) · 20-F (2) · foreign-issuer (1) · reporting (1) · regulatory-update (1)
Key Numbers
- Commission File Number: 001-39591 — Identifies the specific SEC filing for iHuman Inc.
- Share Repurchase Program Value: 144,000,000 — Indicates the scale of the share repurchase program, though specific dollar amounts spent are not detailed in this snippet.
- Fiscal Year End: 2023-12-31 — The end date of the reporting period
- Filing Date: 2024-04-25 — The date the 20-F was filed with the SEC
- Value: 144,000,000 — A financial value mentioned in the filing context (exact label unclear from snippet)
- Business Phone: 86-10-5780-6636 — Contact number for the company
Frequently Asked Questions
What are the latest SEC filings for Ihuman INC. (IH)?
Ihuman INC. has 11 recent SEC filings from Feb 2024 to Mar 2026, including 9 6-K, 2 20-F. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of IH filings?
Across 11 filings, the sentiment breakdown is: 11 neutral. The dominant sentiment is neutral.
Where can I find Ihuman INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ihuman INC. (IH) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Ihuman INC.?
Financial highlights for Ihuman INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for IH?
The investment thesis for IH includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Ihuman INC.?
Key executives identified across Ihuman INC.'s filings include Vivien Weiwei Wang.
What are the main risk factors for Ihuman INC. stock?
Of IH's 11 assessed filings, 0 were flagged high-risk, 2 medium-risk, and 9 low-risk.
What are recent predictions and forward guidance from Ihuman INC.?
Forward guidance and predictions for Ihuman INC. are extracted from SEC filings as they are enriched.